Spyre Therapeutics, Inc. (SYRE) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$99.16
+6.73%
Mkt Cap $8.34B
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 19, 2026 | $142.86M | $90.49M | -36.65% | -$0.66 | -$0.70 | -6.06% |
| Q4 2025 Nov 4, 2025 | — | — | — | -$0.68 | -$0.15 | +77.94% |
| Q3 2025 Aug 5, 2025 | — | — | — | -$0.73 | -$0.49 | +32.88% |
| Q2 2025 May 8, 2025 | — | — | — | -$0.76 | -$0.74 | +2.63% |
| Q1 2025 Feb 27, 2025 | $4.00M | — | — | -$0.89 | -$0.81 | +8.99% |
| Q4 2024 Nov 7, 2024 | $2.63M | — | — | -$0.80 | -$1.36 | -70.00% |
| Q3 2024 Aug 7, 2024 | $4.00M | — | — | -$0.90 | -$0.86 | +4.44% |
| Q2 2024 May 9, 2024 | — | — | — | -$0.90 | -$1.20 | -33.33% |
| Q1 2024 Feb 29, 2024 | $220.00K | $1.04M | +373.64% | -$0.48 | -$2.28 | -375.00% |
| Q4 2023 Nov 9, 2023 | $198.00K | — | — | -$0.84 | -$9.34 | -1011.90% |
| Q3 2023 Aug 11, 2023 | $198.00K | $688.00K | +247.47% | -$4.50 | -$1.66 | +63.11% |
| Q1 2023 Mar 31, 2023 | $184.00K | $198.00K | +7.61% | -$4.50 | -$4.89 | -8.57% |
| Q4 2022 Dec 30, 2022 | $133.33K | $168.00K | +26.00% | -$5.71 | -$7.20 | -26.14% |
| Q3 2022 Sep 29, 2022 | $208.33K | $174.00K | -16.48% | -$6.25 | -$4.84 | +22.57% |
| Q2 2022 Jun 29, 2022 | $709.50K | $625.00K | -11.91% | -$7.95 | -$6.79 | +14.57% |
| Q1 2022 Mar 30, 2022 | — | $1.36M | — | — | -$9.26 | — |
| Q4 2021 Dec 30, 2021 | $1.59M | $3.64M | +128.84% | -$8.54 | -$10.36 | -21.33% |
| Q3 2021 Sep 29, 2021 | — | $1.40M | — | — | -$7.72 | — |
| Q2 2021 Jun 29, 2021 | — | $13.70M | — | — | -$2.60 | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$6.94 | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$9.47 | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$7.24 | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$10.11 | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$14.15 | — |
| Q4 2019 Dec 30, 2019 | — | — | — | — | -$15.31 | — |
| Q3 2019 Sep 30, 2019 | — | — | — | — | -$16.40 | — |
| Q2 2019 Jun 30, 2019 | — | — | — | — | -$13.72 | — |
| Q1 2019 Mar 31, 2019 | — | — | — | — | -$14.79 | — |
| Q4 2018 Dec 30, 2018 | — | $3.89M | — | — | -$13.31 | — |
| Q3 2018 Sep 30, 2018 | — | — | — | — | -$13.55 | — |
| Q2 2018 Jun 30, 2018 | — | $2.38M | — | — | -$11.43 | — |
| Q1 2018 Mar 31, 2018 | — | $1.51M | — | — | -$12.17 | — |
| Q4 2017 Dec 30, 2017 | — | $5.21M | — | — | -$11.25 | — |
| Q3 2017 Sep 30, 2017 | — | $1.26M | — | — | -$12.00 | — |
| Q2 2017 Jun 30, 2017 | — | $1.48M | — | — | -$11.75 | — |
| Q1 2017 Mar 31, 2017 | — | $982.00K | — | — | -$11.68 | — |
| Q4 2016 Dec 30, 2016 | — | $4.63M | — | — | -$13.85 | — |
| Q3 2016 Sep 30, 2016 | — | $1.15M | — | — | -$11.70 | — |
| Q2 2016 Jun 30, 2016 | — | $1.37M | — | — | -$11.53 | — |
| Q1 2016 Mar 31, 2016 | — | $859.00K | — | — | -$9.95 | — |
| Q4 2015 Dec 31, 2015 | — | $6.08M | — | — | -$6.18 | — |
| Q3 2015 Sep 30, 2015 | — | $1.07M | — | — | -$12.51 | — |
| Q2 2015 Jun 30, 2015 | — | $3.43M | — | — | -$5.23 | — |
| Q1 2015 Mar 31, 2015 | — | — | — | — | -$9.05 | — |
| Q4 2014 Dec 31, 2014 | — | — | — | — | -$4.73 | — |
| Q1 2014 Mar 31, 2014 | — | — | — | — | -$5.57 | — |